Liquid Oxygen Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Distribution Channel (Direct Sales, Indirect Sales), By End Use (Hospitals, Outpatient Facilities, Homecare, Others), By Region & Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 6.61 Billion
CAGR (2026-2031)	4.52%
Fastest Growing Segment	Homecare
Largest Market	North America
Market Size (2031)	USD 8.62 Billion

Market Overview

The Global Liquid Oxygen Devices Market will grow from USD 6.61 Billion in 2025 to USD 8.62 Billion by 2031 at a 4.52% CAGR. Liquid oxygen devices are specialized medical systems designed to store and deliver high-concentration oxygen in a cryogenic state, primarily for patients requiring long-term respiratory support. The market’s growth is fundamentally supported by the rising global prevalence of chronic obstructive pulmonary disease (COPD) and an expanding geriatric population, both of which necessitate consistent oxygen therapy. These core demographic and health-related factors provide a sustained demand base that is distinct from transient consumer trends or temporary shifts in healthcare delivery methods.

However, the sector faces a significant challenge regarding the complex logistics and high capital investment required for maintaining the cryogenic supply chain. According to the European Industrial Gases Association, in 2024, the global industrial gas market's value stood at €86.9 billion, a figure that underscores the immense economic scale of the production and distribution infrastructure upon which medical liquid oxygen relies. This intensive capital requirement can impede rapid market expansion, particularly in developing regions where the necessary specialized storage and transportation facilities are often insufficient.

Key Market Drivers

The rapidly expanding geriatric population susceptible to respiratory disorders stands as a primary catalyst for the liquid oxygen devices market, creating sustained demand for high-capacity respiratory support systems. This demographic shift correlates with a rising incidence of severe lung conditions that require consistent, medical-grade oxygen delivery, pushing healthcare systems to stockpile and upgrade their cryogenic equipment. A clear indicator of this escalating respiratory burden is evident in global infection trends. According to the World Health Organization, October 2024, in the 'Global Tuberculosis Report 2024', approximately 10.8 million people fell ill with tuberculosis worldwide in 2023, a resurgence that underscores the critical need for robust oxygen infrastructure to manage acute and chronic respiratory crises.

Simultaneously, the growing preference for home-based long-term oxygen therapy is reshaping the market, driving the development of portable and lightweight liquid oxygen systems that allow patients to maintain mobility while receiving care. This transition from clinical to residential settings is reflected in the performance of major industry players. According to Air Liquide, July 2024, in the 'First Half 2024 Financial Report', their Healthcare business posted sales growth of 4.4%, a rise explicitly supported by the dynamic development of home healthcare services. This surge in home-based modalities directly fuels the manufacturing of specialized storage units, as further evidenced by the broader equipment sector. According to Chart Industries, in 2024, the company reported third-quarter sales of $1.06 billion, marking a 22.4% increase that highlights the expanding commercial scale of cryogenic and medical gas device production.

Download Free Sample Report

Key Market Challenges

The complex logistics and high capital investment required to maintain a cryogenic supply chain represent a formidable barrier to the expansion of the Global Liquid Oxygen Devices Market. Unlike standard medical equipment, liquid oxygen systems rely on an intricate network involving air separation units, specialized vacuum-insulated transport fleets, and cryogenic storage facilities capable of maintaining extremely low temperatures. Establishing and sustaining this infrastructure necessitates substantial upfront financial resources, creating high entry barriers that prevent rapid scalability.

This financial intensity particularly hampers market growth in developing regions where healthcare funding is constrained. The sheer economic scale required to support these operations limits the reach of liquid oxygen devices to well-funded metropolitan centers, often leaving rural or economically disadvantaged areas without access. According to the Compressed Gas Association, in 2025, the compressed gas industry contributed over $10 billion to the U.S. economy, a figure that illustrates the massive economic footprint and resource intensity essential for supporting this sector. In markets lacking this level of established industrial capability, the cost of building such a supply chain from scratch effectively stalls the broader adoption of these life-support devices.

Key Market Trends

The integration of IoT-enabled telemetry and smart monitoring is fundamentally transforming the liquid oxygen devices market by addressing critical supply chain inefficiencies. Unlike traditional delivery models based on fixed schedules, these smart systems utilize sensors to transmit real-time tank level data to suppliers, enabling dynamic route optimization and preventing dangerous stockouts. This digital evolution not only reduces operational costs associated with emergency deliveries but also enhances patient safety by ensuring continuous availability. The commercial impact of this shift toward digitally integrated care is evident in the performance of major healthcare providers. According to Air Liquide, February 2025, in the 'Full Year 2024 Financial Results', the company's Healthcare business revenue increased by 8.6%, a performance explicitly attributed to the dynamic development of value-based home healthcare models that leverage such technological advancements.

Simultaneously, the adoption of advanced vacuum insulation technologies is crucial for mitigating the inherent issue of cryogenic boil-off, thereby extending the viable storage duration of liquid oxygen. Manufacturers are increasingly utilizing high-performance materials and multi-layer insulation techniques to construct storage tanks that minimize thermal transfer, making the long-distance transport and storage of medical oxygen more economically viable. This technological upgrade is driving substantial investment in modern cryogenic infrastructure as providers seek to replace aging, less efficient equipment. This demand for sophisticated containment solutions is reflected in the sales figures of leading equipment manufacturers. According to Chart Industries, July 2025, in the 'Second Quarter 2025 Financial Results', the company reported sales of $1.08 billion, an increase of 4.0% that underscores the growing market uptake of advanced cryogenic technologies and engineered equipment.

Segmental Insights

The Homecare segment constitutes the fastest-growing category within the Global Liquid Oxygen Devices Market, driven by the increasing demand for long-term oxygen therapy in residential settings. This trend is largely supported by the rising prevalence of respiratory ailments such as Chronic Obstructive Pulmonary Disease which require continuous support. Liquid oxygen is particularly suitable for home use as it allows for greater storage density and portability than traditional gas cylinders, thereby enhancing patient independence. Furthermore, global healthcare strategies increasingly focus on reducing hospital readmissions and operational costs, making home-based oxygen delivery a logically preferred and economically viable alternative for chronic care management.

Regional Insights

North America maintains a leading position in the global liquid oxygen devices market, driven primarily by the high prevalence of chronic respiratory disorders such as Chronic Obstructive Pulmonary Disease. The region benefits from substantial healthcare expenditure and a robust infrastructure that facilitates widespread access to home healthcare solutions. Additionally, the presence of key industry manufacturers combined with favorable reimbursement frameworks supports market stability. Stringent but clear guidelines from the U.S. Food and Drug Administration regarding medical device safety further encourage the adoption of these therapeutic technologies across the United States and Canada.

Recent Developments

• In July 2025, Linde announced it had entered into long-term agreements to supply industrial gases for space launch operations, leading to major infrastructure investments in the United States. The company revealed plans to expand its facility in Mims, Florida, to increase liquid oxygen and nitrogen production capacity, with operations expected to begin in 2027. Furthermore, Linde stated it would construct a new air separation unit in Brownsville, Texas, scheduled to start up in early 2026. This new plant was designed to produce liquid oxygen, nitrogen, and argon to support the growing commercial space sector.
• In November 2024, INOX India Ltd (INOXCVA) reported securing a significant engineering, procurement, and construction (EPC) contract during the second quarter of the 2025 fiscal year. The order involved the supply of a storage and vaporizer package for liquid nitrogen and liquid oxygen for a natural gas plant expansion project in Saudi Arabia. Additionally, the company announced it had achieved its highest-ever quarterly order inflow of ₹ 366 Cr, driven by sustained demand for cryogenic storage and distribution equipment across international markets. This reinforced the company's position in the global liquid oxygen devices sector.
• In August 2024, Nikkiso Clean Energy & Industrial Gases Group held a groundbreaking ceremony to expand its manufacturing operations in Wurzen, Germany. The project aimed to double the company's production capacity in Europe for cryogenic pumps and heat exchangers, which are essential components for handling liquid oxygen and other industrial gases. This development was part of a broader strategy to support the transition to clean energy and meet the rising demand for cryogenic equipment in the region. The expanded facility was set to be powered entirely by renewable solar energy upon its completion.
• In March 2024, Chart Industries announced the opening of a new manufacturing facility in Theodore, Alabama, known as "Teddy 2." This expansion was designed to produce the world's largest shop-built cryogenic tanks, with capacities reaching 1,700 cubic meters. These massive storage vessels were engineered to hold liquid gases, including liquid oxygen, hydrogen, and liquefied natural gas, catering to the aerospace, marine, and decarbonization sectors. The facility featured direct access to waterways and railways to lower freight costs and accelerate delivery times for these critical liquid oxygen storage devices.

Key Market Players

• CAIRE Inc.
• Cryofab Inc
• Koninklijke Philips N.V.
• Air Liquide SA
• Inogen Inc
• ErgoMed Inc.
• Taylor-Wharton International LLC
• Inova Labs Inc.
• DeVilbiss Healthcare
• NTK Oxygen Electronics Co. Ltd.

By Distribution Channel	By End Use	By Region
Direct Sales Indirect Sales	Hospitals Outpatient Facilities Homecare Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Liquid Oxygen Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Liquid Oxygen Devices Market, By Distribution Channel:

• Direct Sales
• Indirect Sales

• Liquid Oxygen Devices Market, By End Use:

• Hospitals
• Outpatient Facilities
• Homecare
• Others

• Liquid Oxygen Devices Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE